S, L., X, Z., & Y, T. (2025). Authors' reply to Radiotherapy dosimetry oversights in the RELAX trial: Implications for interpreting taVNS efficacy in neuropathic pain. EClinicalMedicine, 89, 103593. https://doi.org/10.1016/j.eclinm.2025.103593
Chicago Style (17th ed.) CitationS, Li, Zuo X, and Tang Y. "Authors' Reply to Radiotherapy Dosimetry Oversights in the RELAX Trial: Implications for Interpreting TaVNS Efficacy in Neuropathic Pain." EClinicalMedicine 89 (2025): 103593. https://doi.org/10.1016/j.eclinm.2025.103593.
MLA (9th ed.) CitationS, Li, et al. "Authors' Reply to Radiotherapy Dosimetry Oversights in the RELAX Trial: Implications for Interpreting TaVNS Efficacy in Neuropathic Pain." EClinicalMedicine, vol. 89, 2025, p. 103593, https://doi.org/10.1016/j.eclinm.2025.103593.